Paediatric Emergency Medicine

Regenerative medicine, clinical and industrial delivery. A one year programme involving both taught and practical elements leading to the award of a Master’s degree.

The pharmaceutical and life sciences industries are investing in stem cells, either in direct applications where the stem cells themselves would be used for therapy or indirectly, where stem cell derived tissues will be used for drug screening and toxicity testing. With the increasing involvement of the major pharmaceutical companies in this area, as well as many smaller companies, it is clear that there will be a growing demand for a highly skilled workforce. This course is intended to meet current and future needs of the pharmaceutical industry and health care providers by providing a cadre of well trained scientists capable of fulfilling managerial, administrative, research and technical roles within the developing commercial Regenerative Medicine sector.

The programme contains both taught and independent project components and will cover key theoretical and practical aspects of the growth and maintenance of pluripotent stem cell lines, the directed differentiation of these cells into defined tissue phenotypes, and the maintenance of the differentiated state under conditions suitable for drug testing/screening programs. Essential elements of good practice will also be included, such as quality assurance and the regulatory framework that surrounds the derivation, storage and use of human cells. The teaching will be multidisciplinary and will integrate contributions from the fields of medicine, biology, chemistry and bioinformatics. It will consist of the following modules:

• Fundamental Biology of Stem Cells
• Basic Techniques in Regenerative Medicine
• Stem cells and Regenerative Medicine
• Production of differentiated cells
• Regenerative Medicine and the Clinic or Regenerative Medicine and Industry

There will be an industrial placement of 3 months, sited within a life sciences company specialising in aspects of regenerative medicine. Financial assistance may be available to cover travel expenses to the location of the industrial placement. Students may also enroll for the taught component only, leading to the award of a Diploma.

Audience

The course is aimed at high quality graduates in the biomedical sciences who wish to pursue a career within the pharmaceutical industry; some may in fact have started on such a career and be sponsored by their employers to obtain the skills and training that we would offer.

Upper Second (2.1) Honours Degree or equivalent in relevant subjectStudents who do not have English as their first language will require IELTS to at least 6.5 or an equivalent qualification.Students are expected to possess a strong background in one or more of the following areas: bioinformatics, computer sciences and modelling, molecular biology and related sciences, or biotechnology.Physics, mathematics, or other backgrounds will also be considered on a case-by-case basis.Experience working in the pharmaceutical, medical or biotech industries in a laboratory role will be an advantage. English Language Requirements IELTS band: 6.5 TOEFL iBT® test: 92 IMPORTANT NOTE: Since April 2014 the ETS tests (including TOEFL and TOEIC) are no longer accepted for Tier 4 visa applications to the United Kingdom. The university might still accept these tests to admit you to the university, but if you require a Tier 4 visa to enter the UK and begin your degree programme, these tests will not be sufficient to obtain your Visa. The IELTS test is most widely accepted by universities and is also accepted for Tier 4 visas to the UK- learn more.